Business Context and Reporting Period
Company: Columbia Banking System, Inc. (COLB)
Filing Type: Form 8-K (Current Report)
Date: July 11, 2025
Subject: Supplement to the Joint Proxy Statement/Prospectus regarding the proposed merger with Pacific Premier Bancorp, Inc. (Pacific Premier). The filing addresses shareholder litigation and provides additional disclosures regarding the transaction's background, financial advisor opinions, and valuation analyses.
Key Financial Metrics and Transaction Data
This filing does not report Columbia's standalone quarterly revenue, profit, or cash flow. Instead, it provides comparative financial data for peer groups and specific transaction metrics:
- Transaction Consideration: Estimated aggregate merger consideration is approximately $22.5 million (referenced in advisor fee calculation).
- Exchange Ratio: 0.9150 shares of Columbia common stock for each share of Pacific Premier common stock.
- Pro Forma EPS Impact (Columbia):
- Closing (12/31/2025): 13.5% accretion
- 2026E: 14.7% accretion
- 2027E: 13.5% accretion
- 2028E: 13.5% accretion
- Pro Forma TBV Impact (Columbia):
- Closing (12/31/2025): 7.6% dilution
- 2026E: 4.5% dilution
- 2027E: 2.1% dilution
- 2028E: 0.0% dilution
- Pro Forma EPS Impact (Pacific Premier): 84.1% accretion (2026E) and 66.5% accretion (2027E).
- Pro Forma TBV Impact (Pacific Premier): 23.2% dilution at closing.
- Discount Rates (NPV Analysis): Columbia (11.07%); Pacific Premier (11.57%).
Material Changes and Litigation
The primary material event is the filing of shareholder lawsuits challenging the proposed merger, prompting the companies to voluntarily supplement disclosures to moot certain claims.
- Siegel v. Columbia Banking System, Inc. et al.: Filed June 24, 2025, in Superior Court of Washington. Alleges breach of fiduciary duty, negligent misrepresentation, and concealment regarding the Joint Proxy Statement/Prospectus.
- Clark v. Pacific Premier Bancorp, Inc. et al.: Filed June 24, 2025, in Supreme Court of New York. Alleges negligent representation and concealment.
- Parshall v. Pacific Premier Bancorp, Inc. et al.: Filed June 25, 2025, in Supreme Court of New York. Similar allegations to Clark.
- Relief Sought: Injunctive relief to stop the transaction/vote, rescission of the transaction, damages, and corrected disclosures.
- Company Response: Columbia and Pacific Premier deny all allegations and assert the claims are without merit. However, they are voluntarily supplementing the proxy statement to avoid delay and expense.
Guidance, Outlook, and Management Commentary
Strategic Rationale: Management and the Board emphasized the transaction's ability to accelerate Columbia's expansion into Southern California, leverage Pacific Premier's commercial banking strategy, and achieve synergies through complementary deposit bases and loan portfolios.
Board Process: The filing details specific board meetings (Feb 19, Mar 10, Mar 19, Apr 22, 2025) where the Columbia Board reviewed strategic fit, valuation, capital levels, and integration risks. The Pacific Premier Board also conducted a strategic review, contacting three other potential partners who declined to pursue a transaction due to economic uncertainty, integration timing, or valuation concerns.
Financial Advisor Opinions:
- Columbia (PSC): Selected comparable companies and precedent transactions to support the fairness of the transaction. Used a discount rate of 11.07% for NPV analysis.
- Pacific Premier (KBW): Selected comparable transactions with price-to-tangible book value multiples ranging from 1.00x to 1.84x. Used a discount rate range of 12.5% to 14.5% for dividend discount models.
Risks and Contingencies: The filing lists standard forward-looking risks including regulatory approval delays, integration challenges, economic downturns, interest rate volatility, and the potential for the transaction to be terminated. It specifically notes the risk that the anticipated benefits may not be realized.
Investor Verification Checklist
- Verify the status of the three pending lawsuits (Siegel, Clark, Parshall) and whether the supplemental disclosures have successfully mooted the plaintiffs' claims.
- Review the full Joint Proxy Statement/Prospectus (Amendment No. 1) to understand the complete context of the amended disclosures regarding board meetings and strategic alternatives.
- Confirm the final exchange ratio and pro forma financial metrics, noting the dilution to Columbia's tangible book value in the near term.
- Assess the regulatory approval status, as the transaction is contingent upon necessary approvals which may impose conditions.
- Monitor the integration timeline and the specific synergies cited (Southern California expansion, commercial banking growth) against actual post-merger performance.